PNC Financial Services Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.8K Sell
2,416
-321
-12% -$11.7K ﹤0.01% 2796
2025
Q1
$99.1K Buy
2,737
+1,911
+231% +$69.2K ﹤0.01% 2666
2024
Q4
$34.8K Buy
826
+143
+21% +$6.02K ﹤0.01% 3287
2024
Q3
$37.9K Buy
683
+185
+37% +$10.3K ﹤0.01% 3218
2024
Q2
$20.5K Sell
498
-16
-3% -$658 ﹤0.01% 3468
2024
Q1
$24K Buy
514
+341
+197% +$15.9K ﹤0.01% 3359
2023
Q4
$8.27K Sell
173
-299
-63% -$14.3K ﹤0.01% 3795
2023
Q3
$16.8K Buy
472
+42
+10% +$1.5K ﹤0.01% 3511
2023
Q2
$19.8K Buy
430
+379
+743% +$17.5K ﹤0.01% 3564
2023
Q1
$2.04K Sell
51
-176
-78% -$7.05K ﹤0.01% 4305
2022
Q4
$10.5K Buy
227
+43
+23% +$1.99K ﹤0.01% 3761
2022
Q3
$7K Sell
184
-20
-10% -$761 ﹤0.01% 3884
2022
Q2
$12K Sell
204
-86
-30% -$5.06K ﹤0.01% 3734
2022
Q1
$20K Buy
290
+164
+130% +$11.3K ﹤0.01% 3582
2021
Q4
$10K Sell
126
-43
-25% -$3.41K ﹤0.01% 3792
2021
Q3
$15K Buy
169
+31
+22% +$2.75K ﹤0.01% 3621
2021
Q2
$14K Buy
138
+62
+82% +$6.29K ﹤0.01% 3600
2021
Q1
$9K Buy
76
+30
+65% +$3.55K ﹤0.01% 3684
2020
Q4
$6K Sell
46
-80
-63% -$10.4K ﹤0.01% 3686
2020
Q3
$9K Buy
126
+36
+40% +$2.57K ﹤0.01% 3546
2020
Q2
$7K Buy
+90
New +$7K ﹤0.01% 3567
2019
Q4
Sell
-18,921
Closed -$809K 4078
2019
Q3
$809K Sell
18,921
-8,069
-30% -$345K ﹤0.01% 1353
2019
Q2
$1.72M Buy
26,990
+26,971
+141,953% +$1.71M ﹤0.01% 1070
2019
Q1
$2K Buy
19
+3
+19% +$316 ﹤0.01% 3888
2018
Q4
$0 Hold
16
﹤0.01% 4153
2018
Q3
$2K Buy
+16
New +$2K ﹤0.01% 3963
2018
Q1
Sell
-51
Closed -$2K 4261
2017
Q4
$2K Buy
+51
New +$2K ﹤0.01% 4018
2016
Q3
Sell
-200
Closed -$10K 4218
2016
Q2
$10K Sell
200
-7
-3% -$350 ﹤0.01% 3561
2016
Q1
$13K Sell
207
-30
-13% -$1.88K ﹤0.01% 3456
2015
Q4
$26K Sell
237
-196
-45% -$21.5K ﹤0.01% 3166
2015
Q3
$42K Buy
433
+178
+70% +$17.3K ﹤0.01% 2970
2015
Q2
$26K Buy
255
+137
+116% +$14K ﹤0.01% 3383
2015
Q1
$7K Buy
+118
New +$7K ﹤0.01% 3921